Whitehawk Therapeutics (WHWK) Change in Acquisitions & Divestments (2022 - 2026)

Whitehawk Therapeutics (WHWK) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $38.6 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 162.82% year-over-year to $38.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $83.8 million (up 41.76% YoY) and the FY2025 annual result came in at $59.8 million, down 5.51% from the prior year.
• Change in Acquisitions & Divestments retreated to $38.6 million in Q1 2026 per WHWK's latest filing, from $39.8 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $51.2 million in Q2 2023 and bottomed at $2.0 million in Q3 2025.
• The 5-year median for Change in Acquisitions & Divestments is $17.1 million (2023), against an average of $23.3 million.
• Peak annual rise in Change in Acquisitions & Divestments reached 198.57% in 2025, while the deepest fall reached 86.86% in 2025.
• Tracing WHWK's Change in Acquisitions & Divestments over 5 years: stood at $12.8 million in 2022, then surged by 44.02% to $18.4 million in 2023, then declined by 27.47% to $13.3 million in 2024, then soared by 198.57% to $39.8 million in 2025, then retreated by 2.89% to $38.6 million in 2026.
• Per Business Quant, the three latest WHWK Change in Acquisitions & Divestments figures stand at $38.6 million (Q1 2026), $39.8 million (Q4 2025), and $2.0 million (Q3 2025).

Peer Comparison